Characteristic | HIV PCR negative (1239 neonates) | HIV PCR positive (32 neonates) | p value |
---|---|---|---|
Male | 666/1234 (54.0%) | 14/32 (43.8%) | 0.252 |
Any antenatal care | 957/1136 (84.2%) | 21/28 (75.0%) | 0.187 |
Normal vaginal delivery | 570/1176 (48.5%) | 18/29 (62.1%) | 0.348 |
Multiple gestation | 162/1227 (13.2%) | 3/30 (10.0%) | 0.608 |
Nulliparous mother | 148/1065 (13.9%) | 3/27 (11.1%) | 0/944 |
Chorioamnionitis | 318/1085 (3.5%) | 1/27 (3.7%) | 0.955 |
Maternal hypertension | 143/1091 (13.1%) | 3/27 (11.1%) | 0.761 |
Maternal tuberculosis | 28/1113 (2.5%) | 1/28 (3.6%) | 0.726 |
Maternal diabetes mellitus | 12/1139 (1.1%) | 0/32 (0%) | 0.578 |
Maternal syphilis | 44/1135 (3.9%) | 4/28 (14.3%) | 0.006 |
Bag mask ventilation at birth | 307/1239 (24.7%) | 9/30 (30.0%) | 0.523 |
Ventilatory support | |||
 CPAP | 410/1037 (39.5%) | 11/24 (45.8%) | 0.533 |
 Mechanical ventilation | 207/1039 (19.9%) | 3/24 (12.5%) | 0.367 |
Life threatening congenital abnormality | 77/1224 (6.3%) | 1/32 (3.1%) | 0.464 |
Culture proven sepsis on or before day 3 | 55/1211 (4.5%) | 1/30 (5.3%) | 0.753 |
Culture proven sepsis after day 3 | 227/1227 (18.5%) | 9/32 (28.1%) | 0.168 |
Neonatal jaundice requiring phototherapy | 364/1196 (30.4%) | 8/31 (25.8%) | 0.586 |
Necrotising enterocolitis (stage 2 or 3) | 66/1220 (5.4%) | 1/30 (3.3%) | 0.618 |
Hypoxic ischemic encephalopathy | 79/822 (9.6%) | 1/23 (4.3%) | 0.395 |
Died | 136/1239 (11.0%) | 5/32 (15.6%) | 0.408 |